Aortic valve stenosis” is an often-overlooked condition and a growing health concern in ageing societies such as Thailand.

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

BayCare's Morton Plant Hospital in Clearwater recently completed the world's first TAV-in-TAV as part of a study called ...

Gregg Jumper is used to pressure: from the weight of a loaded bar to the weight of relief as he breaks yet another national record – his own.

Olive Hospital has achieved a major breakthrough in the field of Interventional Cardiology by successfully completing its ...

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and ...

Patients with aortic stenosis were excluded from earlier trials of the SGLT2 inhibitor, but new data confirm they too can ...